Clinical Trial Results:
A Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group Safety Study of
Pulmonary Function in Patients with Reduced Lung Function Treated with BOTOX®
(Botulinum Toxin Type A) Purified Neurotoxin Complex for Focal Upper Limb
Spasticity Due to Upper Motor Neuron Syndrome
Summary
|
|
EudraCT number |
2005-004834-42 |
Trial protocol |
HU CZ |
Global completion date |
17 Aug 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
03 Nov 2016
|
First version publication date |
03 Nov 2016
|
Other versions |
|
Summary report(s) |
CT.gov Summary Results - Study 191622-057 - Edura 2005-004834-42 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.